Skip to main content

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) Investor Lawsuit Filed Against Directors

  • Investors who purchased shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) and currently hold any of those NASDAQ: RARE shares have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

An investor in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) filed a lawsuit against directors of Ultragenyx Pharmaceutical Inc over alleged excessive pay of certain directors. The plaintiff alleges alleging that the board has breached its fiduciary duty and engaged in self-dealing, unjust enrichment and waste in approving a compensation plan that grossly overcompensates ...



You must register (for free) or login to view the entire case.